Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Public ClinicalTrials.gov record NCT02914314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 4 Years of Age With Epilepsy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the pharmacokinetics (PK) of perampanel during the Maintenance Period of the Core Study following oral suspension administration given as an adjunctive therapy in pediatric participants from 1 month to less than 4 years of age with epilepsy.
Study identification
- NCT ID
- NCT02914314
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 1 Month to 4 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 20, 2017 (Actual)
- Primary completion
- Aug 23, 2022 (Actual)
- Completion
- Apr 25, 2023 (Actual)
- Last update posted
- Mar 15, 2024
2017 – 2023
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | — |
| David Geffen School of Medicine at UCLA | Los Angeles | California | 90095-1752 | — |
| NW FL Clinical Research Group, LL-ClinEdge- PPDS | Gulf Breeze | Florida | 32561 | — |
| Axcess Medical Research | Loxahatchee Groves | Florida | 33470 | — |
| Pediatric Neurology PA | Orlando | Florida | 32819 | — |
| Pediatric Epilepsy And Neurology Specialists | Tampa | Florida | 33609 | — |
| Children's Healthcare of Atlanta | Atlanta | Georgia | 30329 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| Carle Foundation Hospital | Urbana | Illinois | 61801 | — |
| University of Kentucky | Lexington | Kentucky | 40536-0284 | — |
| Children's Mercy Hospital | Kansas City | Missouri | 64108-4619 | — |
| Children's Hospital at Saint Peter's University Hospital | New Brunswick | New Jersey | 08901 | — |
| Duke University Medical Center, Children's Health Center | Durham | North Carolina | 27710 | — |
| Atrium Health Wake Forest Baptist Medical Center PPDS | Winston-Salem | North Carolina | 27157 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Child Neurology Consultants of Austin | Austin | Texas | 78749 | — |
| Road Runner Research, Ltd | San Antonio | Texas | 78249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02914314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 15, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02914314 live on ClinicalTrials.gov.